Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

B&L eyes larger profits

This article was originally published in The Tan Sheet

Executive Summary

Annual operating profits will increase by $90 mil. in 2005, with about 60% of savings realized by 2004, as a result of various cost-cutting initiatives announced July 25. Bausch & Lomb's plans include consolidation or closure of certain plants, which will eliminate roughly 325 jobs, deliver annual cost savings of $16 mil. by 2005, firm says. Other efforts include: expanding best-practice manufacturing processes on worldwide basis; consolidating all procurement activities into global function; rationalization of several contact lens, surgical products; development of global IT platform. Roughly 450 jobs will be eliminated; restructuring charges could total $20 mil. and will be recorded in Q3. B&L's second quarter sales jumped 14.1% to $458.4 mil., with net earnings more than tripling to $21.8 mil. from $6.8 mil. last year...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel